ABGC Boards - Final Review Questions and
Answers 100% Pass
Hereditary Breast and Ovarian Cancer - ✔✔BRCA 1/2
Breast 50-87%
Second primary tumor 50-64%
BRCA 1: 20-45% BRCA 2: 10-30%
BRCA 2: Male breast 6-10%
Li-Fraumeni Syndrome - ✔✔-Sarcoma, breast, leukemia, adrenal and many others
-May present in almost every way (ie all family members with same cancers or all with different)
-Adrenocortical carcinoma considered pathognomonic
-50% have some type by 30, 90% by age 60
-TP53 accounts for 70% of individuals
Beckwith-Wiedemann - ✔✔Overgrowth disorder in children, tongue, viscera, hemihyperplasia,
abdominal wall defects, ear pits and creases. Pancreatic hyperplasia leads to neonatal hypoglycemia and
MR
Airway and feeding difficulties,
Methylation abnormalities/imprinting disorder 11p15.5 (need mom, dad is shut off)
Page 1/98
Crafted for Academic Insight by KatelynWhitman. All rights reserved © 2025
,-Childhood embryonal tumors (7.5%), Wilms (Kidney), hepatoblastoma, neuroblastoma,
rhabdomyosarcoma
hepatoblastoma - ✔✔malignant liver tumor, most common primary liver malignancy in children,
associated with BWS
Wilms tumor - ✔✔AKA kidney tumor, associated with BWS
oncogene - ✔✔A gene having the potential to cause a normal cell to become cancerous.
Lynch Syndrome - ✔✔cancer predisposition syhndrome affecting increased 50-80% risk for colon cancer
before age 50
caused by germline pathogenic variant in one of four mismatch repair genes (MMR)
-MSH2
-MSH6
-MLH1
-PMS2
MLH1 and MSH2 variants account for approximately 90% of pathogenic variants
-Germline deletions in EPCAM inactivate MSH2
Page 2/98
Crafted for Academic Insight by KatelynWhitman. All rights reserved © 2025
,Adrenocortical carcinoma - ✔✔Cancer of the outer layer of the adrenal glands, commonly associated with
Li-Fraumeni Syndrome
1.) MSI/MMR histochemistry (MSH2/MSH6 complexes, where MSH6 is absent if MSH2 is),
(MLH1/PMS2 complexes where PMS2 is absent if MLH1 is absent)
-MSH2 causes loss of MSH6
-MLH1 causes loss of PMS2
2.) BRAF (sporadic)
3.) If BRAF neg, methylation neg, proceed to MMR genetic testing - ✔✔What is the testing algorithm for
lynch syndrome?
Familial adenomatous polyposis - ✔✔Onset with hundreds of polyps forming in colon and rectum (at
least 10-20 cumulative)
-Mostly inherited
-Classic (polyps at age 16) Cancer by 50 vs Attenuated (start of disease later in life and fewer than 100
polyps develop)
-Hepatboblastoma
-Desmoid tumor
-Genetic testing of APC gene
Cowden Syndrome - ✔✔Lifetime risk of ~35% to develop thyroid cancer, associations with benign
thyroid disease (adenoma, multinodular goitar)
Page 3/98
Crafted for Academic Insight by KatelynWhitman. All rights reserved © 2025
, Other cancers and family history clues: breast cancer, endometrial cancer, follicular thyroid cancer, GI
hamartomas, macrocephaly, mucocutaneous lesions, macular pimentation, autism, colon cancer, lipomas,
renal cell carcinoma, intellectual disability, vascular anomalies
Gene involved: PTEN
hamartoma - ✔✔mostly benign, focal malformation that resembles a neoplasm in the tissue of its origin.
This is not a malignant tumor, it grows at the same rate as the surrounding tissue. It is composed of tissue
elements normally found at that site, but they are growing in a disorganized manner.
Multiple Endocrine Neoplasia Type 2 - ✔✔Medullary thyroid cancer risk, pheochromocytomas,
Hyperparathroidism (elevated blood calcium, hypercalcemia=osteoporosis, kidney stones, fatigue,
generalized aches, depression, impaired concentration, constipation, hypertension)
-MEN2A
-MEN2B
-FMTC
RET testing offered to all patients with medullary thyroid cancer
Pheochromocytoma - ✔✔tumor of the adrenal medulla tissue characterized by increased formation of
catecholamines
Multiple Endocrine Neoplasia Type 2A - ✔✔Diagnosed by 2 or more endocine tumors in a single person
or in close relatives
Page 4/98
Crafted for Academic Insight by KatelynWhitman. All rights reserved © 2025
Answers 100% Pass
Hereditary Breast and Ovarian Cancer - ✔✔BRCA 1/2
Breast 50-87%
Second primary tumor 50-64%
BRCA 1: 20-45% BRCA 2: 10-30%
BRCA 2: Male breast 6-10%
Li-Fraumeni Syndrome - ✔✔-Sarcoma, breast, leukemia, adrenal and many others
-May present in almost every way (ie all family members with same cancers or all with different)
-Adrenocortical carcinoma considered pathognomonic
-50% have some type by 30, 90% by age 60
-TP53 accounts for 70% of individuals
Beckwith-Wiedemann - ✔✔Overgrowth disorder in children, tongue, viscera, hemihyperplasia,
abdominal wall defects, ear pits and creases. Pancreatic hyperplasia leads to neonatal hypoglycemia and
MR
Airway and feeding difficulties,
Methylation abnormalities/imprinting disorder 11p15.5 (need mom, dad is shut off)
Page 1/98
Crafted for Academic Insight by KatelynWhitman. All rights reserved © 2025
,-Childhood embryonal tumors (7.5%), Wilms (Kidney), hepatoblastoma, neuroblastoma,
rhabdomyosarcoma
hepatoblastoma - ✔✔malignant liver tumor, most common primary liver malignancy in children,
associated with BWS
Wilms tumor - ✔✔AKA kidney tumor, associated with BWS
oncogene - ✔✔A gene having the potential to cause a normal cell to become cancerous.
Lynch Syndrome - ✔✔cancer predisposition syhndrome affecting increased 50-80% risk for colon cancer
before age 50
caused by germline pathogenic variant in one of four mismatch repair genes (MMR)
-MSH2
-MSH6
-MLH1
-PMS2
MLH1 and MSH2 variants account for approximately 90% of pathogenic variants
-Germline deletions in EPCAM inactivate MSH2
Page 2/98
Crafted for Academic Insight by KatelynWhitman. All rights reserved © 2025
,Adrenocortical carcinoma - ✔✔Cancer of the outer layer of the adrenal glands, commonly associated with
Li-Fraumeni Syndrome
1.) MSI/MMR histochemistry (MSH2/MSH6 complexes, where MSH6 is absent if MSH2 is),
(MLH1/PMS2 complexes where PMS2 is absent if MLH1 is absent)
-MSH2 causes loss of MSH6
-MLH1 causes loss of PMS2
2.) BRAF (sporadic)
3.) If BRAF neg, methylation neg, proceed to MMR genetic testing - ✔✔What is the testing algorithm for
lynch syndrome?
Familial adenomatous polyposis - ✔✔Onset with hundreds of polyps forming in colon and rectum (at
least 10-20 cumulative)
-Mostly inherited
-Classic (polyps at age 16) Cancer by 50 vs Attenuated (start of disease later in life and fewer than 100
polyps develop)
-Hepatboblastoma
-Desmoid tumor
-Genetic testing of APC gene
Cowden Syndrome - ✔✔Lifetime risk of ~35% to develop thyroid cancer, associations with benign
thyroid disease (adenoma, multinodular goitar)
Page 3/98
Crafted for Academic Insight by KatelynWhitman. All rights reserved © 2025
, Other cancers and family history clues: breast cancer, endometrial cancer, follicular thyroid cancer, GI
hamartomas, macrocephaly, mucocutaneous lesions, macular pimentation, autism, colon cancer, lipomas,
renal cell carcinoma, intellectual disability, vascular anomalies
Gene involved: PTEN
hamartoma - ✔✔mostly benign, focal malformation that resembles a neoplasm in the tissue of its origin.
This is not a malignant tumor, it grows at the same rate as the surrounding tissue. It is composed of tissue
elements normally found at that site, but they are growing in a disorganized manner.
Multiple Endocrine Neoplasia Type 2 - ✔✔Medullary thyroid cancer risk, pheochromocytomas,
Hyperparathroidism (elevated blood calcium, hypercalcemia=osteoporosis, kidney stones, fatigue,
generalized aches, depression, impaired concentration, constipation, hypertension)
-MEN2A
-MEN2B
-FMTC
RET testing offered to all patients with medullary thyroid cancer
Pheochromocytoma - ✔✔tumor of the adrenal medulla tissue characterized by increased formation of
catecholamines
Multiple Endocrine Neoplasia Type 2A - ✔✔Diagnosed by 2 or more endocine tumors in a single person
or in close relatives
Page 4/98
Crafted for Academic Insight by KatelynWhitman. All rights reserved © 2025
